Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomes.
Zarranz-Ventura J, Parrado-Carrillo A, Nguyen V, Sararols L, Garay-Aramburu G, Puzo M, Arruabarrena C, Figueras-Roca M, Gillies MC, Casaroli-Marano RP; from the writing committee of the Fight Retinal Blindness Spain (FRB! Spain) Users Group. Zarranz-Ventura J, et al. Among authors: sararols l. Clin Exp Ophthalmol. 2022 Apr;50(3):312-324. doi: 10.1111/ceo.14054. Epub 2022 Feb 20. Clin Exp Ophthalmol. 2022. PMID: 35106882 Free article.
Single-Chain Antibody Fragment VEGF Inhibitor RTH258 for Neovascular Age-Related Macular Degeneration: A Randomized Controlled Study.
Holz FG, Dugel PU, Weissgerber G, Hamilton R, Silva R, Bandello F, Larsen M, Weichselberger A, Wenzel A, Schmidt A, Escher D, Sararols L, Souied E. Holz FG, et al. Among authors: sararols l. Ophthalmology. 2016 May;123(5):1080-9. doi: 10.1016/j.ophtha.2015.12.030. Epub 2016 Feb 20. Ophthalmology. 2016. PMID: 26906165 Free article. Clinical Trial.
A Collaborative Retrospective Study on the Efficacy and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema: The European DME Registry Study.
Rosenblatt A, Udaondo P, Cunha-Vaz J, Sivaprasad S, Bandello F, Lanzetta P, Kodjikian L, Goldstein M, Habot-Wilner Z, Loewenstein A; ARTES Study Group. Rosenblatt A, et al. Ophthalmology. 2020 Mar;127(3):377-393. doi: 10.1016/j.ophtha.2019.10.005. Epub 2019 Oct 10. Ophthalmology. 2020. PMID: 31932090 Free article.
Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2-year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! Registry.
Gabrielle PH, Nguyen V, Creuzot-Garcher C, Miguel L, Alforja S, Sararols L, Casaroli-Marano RP, Zarranz-Ventura J, Gillies M, Arnold J, Barthelmes D. Gabrielle PH, et al. Among authors: sararols l. Acta Ophthalmol. 2022 Feb;100(1):e288-e296. doi: 10.1111/aos.14893. Epub 2021 May 6. Acta Ophthalmol. 2022. PMID: 33960115 Free PMC article.
Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry.
Bhandari S, Gabrielle PH, Nguyen V, Daien V, Viola F, Bougamha W, Young S, Romero-Nuñez B, Figueras-Roca M, Zarranz-Ventura J, Barthelmes D, Sararols L, Gillies M, Creuzot-Garcher C. Bhandari S, et al. Among authors: sararols l. Ophthalmol Ther. 2022 Apr;11(2):797-810. doi: 10.1007/s40123-022-00473-3. Epub 2022 Feb 18. Ophthalmol Ther. 2022. PMID: 35179714 Free PMC article.
Incidence, Risk Factors, and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-VEGF for Retinal Diseases: Data from the Fight Retinal Blindness! Registry.
Gabrielle PH, Nguyen V, Arnould L, Viola F, Zarranz-Ventura J, Barthelmes D, Creuzot-Garcher C, Gillies M; Fight Retinal Blindness! Study Group. Gabrielle PH, et al. Ophthalmol Retina. 2022 Nov;6(11):1044-1053. doi: 10.1016/j.oret.2022.05.008. Epub 2022 May 16. Ophthalmol Retina. 2022. PMID: 35589075 Free article.
34 results